TSCAN THERAPEUTICS
TScan is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company’s lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
TSCAN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.tscan.com
Total Employee:
101+
Status:
Active
Contact:
857-399-9500
Email Addresses:
[email protected]
Total Funding:
347.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Google Font API Google Tag Manager WordPress Google Maps Content Delivery Network LetsEncrypt Amazon
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Visum Pharma
Visum Pharma is a pharmaceutical company that develops therapeutics for treatment in the areas of neurodegeneration and cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - TScan Therapeutics
RA Capital Management
RA Capital Management investment in Series C - TScan Therapeutics
Longwood Fund
Longwood Fund investment in Series C - TScan Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - TScan Therapeutics
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - TScan Therapeutics
Pitango VC
Pitango VC investment in Series C - TScan Therapeutics
BlackRock
BlackRock investment in Series C - TScan Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series C - TScan Therapeutics
Google Ventures
Google Ventures investment in Series C - TScan Therapeutics
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research investment in Series B - TScan Therapeutics
Key Employee Changes
Official Site Inspections
http://www.tscan.com Semrush global rank: 3.28 M Semrush visits lastest month: 4.35 K
- Host name: 123.237.196.104.bc.googleusercontent.com
- IP address: 104.196.237.123
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "TScan Therapeutics"
TScan Therapeutics - Crunchbase Company Profile
TScan is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of …See details»
Our Company – TScan Therapeutics
TScan was founded in early 2018 to discover and develop transformational TCR-Ts using a novel T cell target discovery platform developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and …See details»
Home – TScan Therapeutics
TScan is a clinical-stage biopharmaceutical company dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. How We're Different. News. TScan Therapeutics …See details»
TScan Therapeutics - Funding, Financials, Valuation & Investors
TScan Therapeutics is registered under the ticker NASDAQ:TCRX . Their stock opened with $15.00 in its Jul 15, 2021 IPO. Stock Symbol NASDAQ:TCRX ; Valuation at IPO $359M; …See details»
TScan Therapeutics - Company Profile
TScan Therapeutics. TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics was …See details»
Management – TScan Therapeutics
About TScan. TScan is a clinical-stage biopharmaceutical company dedicated to changing lives by discovering new cancer targets and developing safe and effective T cell therapies for patients.See details»
TScan Therapeutics Reports Second Quarter 2024 Financial Results …
The Company signed a letter of intent with a global contract development and manufacturing organization (CDMO) to initiate manufacturing activities for pivotal trials and …See details»
KOL Event - ir.tscan.com
Nov 20, 2024 TScan intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange …See details»
TScan Therapeutics Named Top Place to Work by The Boston …
WALTHAM, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell …See details»
How Does TScan Therapeutics Work? – CANVAS, SWOT, PESTEL
Dec 19, 2024 [cbm_blg_rlnkng]TScan Therapeutics is a cutting-edge biotechnology company focused on revolutionizing the way we approach cancer treatment. By harnessing the power of …See details»
Investors – TScan Therapeutics
TScan is a clinical-stage biopharmaceutical company dedicated to changing lives by discovering new cancer targets and developing safe and effective T cell therapies for patients. …See details»
Sign In
Welcome to TSCAN's Cloud Services. We've recently made the transition to the Cloud by partnering with Microsoft Azure. You may find yourself at this page, by having either; Clicked …See details»
TScan Therapeutics Named a Top Place to Work by The Boston …
WALTHAM, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor …See details»
Partners – TScan Therapeutics
In May 2023, Amgen (NASDAQ: AMGN) and TScan Therapeutics initiated a multi-year collaboration that harnesses TScan’s proprietary target discovery platform, TargetScan, to …See details»
T-Scan - Crunchbase Company Profile & Funding
Organization. T-Scan . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 206-285-6322; Lists …See details»
Record Retrieval Workflows - T-Scan
Go to Order Records or contact us at [email protected] or by phoning 800.285.1507. We will assign an account specialist and get to work. We will assign an account specialist and get to work. ASee details»
ir.tscan.com
Mar 9, 2025 This Registration Statement on Form S-8 registers (i) 5,187,143 additional shares of the Registrant’s common stock, $0.0001 par value per share (“Common Stock”), under the …See details»
T-Scan Online FAQ | Trusted by Top Law Firms, T-Scan
Step 2: Apply Conditional Forwarding to your organization’s internal DNS server for the tscan.biz domain. In short, we want any requests for the tscan.biz domain to be resolved by Google’s …See details»
TScan Therapeutics Announces Upcoming Presentation at the TD …
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor …See details»
Patient Overview - TScan Therapeutics
TScan is working on methods to improve the ability of T cells to recognize and kill cancer cells more efficiently. There are different types of T cell therapies, and some have been approved …See details»